Author: OurCrowd

[Ursa Major in PR Newswire] Ursa Major awarded U.S. Air Force contract to develop flight-ready rocket engine for launch in 2022

Aug 31, 2022 |

DENVER, Aug. 31, 2022 /PRNewswire/ — Ursa Major, America’s only privately funded company that focuses solely on rocket propulsion, today announced a contract under the U.S. Air Force Tactical Funding Increase (TACFI) program. Under the agreement, Ursa Major will provide a flight-qualified 5,000-pound thrust, oxygen-rich staged combustion “Hadley” rocket engine, suited for both the booster and upper-stage phases of launch for satellites into low-earth orbit. Read more...

Read More

[BrightInsight in GlobeNewswire] BrightInsight names Elisabethann Wright of Cooley to its Digital Health Advisory Council

Aug 30, 2022 |

SAN JOSE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Elisabethann Wright, Partner at Cooley, to the BrightInsight Advisory Council. Ms. Wright is the latest to join this group of esteemed industry experts working with the BrightInsight Leadership Team to advance the company’s vision to transform patient outcomes globally through the power of digital technology. Read...

Read More

[Aria Pharmaceuticals in PR Newswire] Aria Pharmaceuticals advances pipeline with six provisional US patents filed across three diseases

Aug 30, 2022 |

PALO ALTO, Calif., Aug. 30, 2022 /PRNewswire/ — Aria Pharmaceuticals, a pharmaceutical company focused on bringing first-in-class small molecules to market, announced that the company has successfully filed a total of six provisional patents with the United States Patent and Trademark Office (USPTO) for lead candidates in its lupus, idiopathic pulmonary fibrosis (IPF), and chronic kidney disease (CKD) research programs. Read...

Read More